Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation

por Huang, Ao, Guo, De-Zhen, Wang, Yu-Peng, Yang, Guo-Huan, Sun, Qi-Man, Zhang, Xin, He, Yi-Feng, Song, Kang, Huang, Xiao-Wu, Yang, Xin-Rong, Fan, Jia, Zhou, Jian, Hu, Jie
Publicado 2021

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis

por Guo, Xiao-Jun, Huang, Xiao-Yong, Yang, Xuan, Lu, Jia-Cheng, Wei, Chuan-Yuan, Gao, Chao, Pei, Yan-Zi, Chen, Yi, Sun, Qi-Man, Cai, Jia-Bin, Zhou, Jian, Fan, Jia, Ke, Ai-Wu, Shi, Yujiang G., Shen, Ying-Hao, Zhang, Peng-Fei, Shi, Guo-Ming, Yang, Guo-Huan
Publicado 2023

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation

por Hu, Jie, Wang, Zheng, Fan, Jia, Dai, Zhi, He, Yi-Feng, Qiu, Shuang-Jian, Huang, Xiao-Wu, Sun, Jian, Xiao, Yong-Sheng, Song, Kang, Shi, Ying-Hong, Sun, Qi-Man, Yang, Xin-Rong, Shi, Guo-Ming, Yu, Lei, Yang, Guo-Huan, Ding, Zhen-Bin, Gao, Qiang, Tang, Zhao-You, Zhou, Jian
Publicado 2011

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 stu...

por Shi, Guo-Ming, Huang, Xiao-Yong, Wu, Dong, Sun, Hui-Chuan, Liang, Fei, Ji, Yuan, Chen, Yi, Yang, Guo-Huan, Lu, Jia-Cheng, Meng, Xian-Long, Wang, Xin-Ying, Sun, Lei, Ge, Ning-Ling, Huang, Xiao-Wu, Qiu, Shuang-Jian, Yang, Xin-Rong, Gao, Qiang, He, Yi-Feng, Xu, Yang, Sun, Jian, Ren, Zheng-Gang, Fan, Jia, Zhou, Jian
Publicado 2023

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma

por Guo, Xiao-Jun, Lu, Jia-Cheng, Zeng, Hai-Ying, Zhou, Rong, Sun, Qi-Man, Yang, Guo-Huan, Pei, Yan-Zi, Meng, Xian-Long, Shen, Ying-Hao, Zhang, Peng-Fei, Cai, Jia-Bin, Huang, Pei-Xin, Ke, Ai-Wu, Shi, Ying-Hong, Zhou, Jian, Fan, Jia, Chen, Yi, Yang, Liu-Xiao, Shi, Guo-Ming, Huang, Xiao-Yong
Publicado 2021

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study

por Shi, Guo‐Ming, Huang, Xiao‐Yong, Wen, Tian‐Fu, Song, Tian‐Qiang, Kuang, Ming, Mou, Hai‐Bo, Bao, Le‐Qun, Zhao, Hai‐Tao, Zhao, Hong, Feng, Xie‐Lin, Zhang, Bi‐Xiang, Peng, Tao, Zhang, Yu‐Bao, Li, Xiang‐Cheng, Yu, Hong‐Sheng, Cao, Yu, Liu, Lian‐Xin, Zhang, Ti, Wang, Wei‐Lin, Ran, Jiang‐Hua, Liu, Ying‐Bin, Gong, Wei, Chen, Ming‐Xia, Cao, Lian, Luo, Yang, Wang, Yan, Zhou, Hui, Yang, Guo‐Huan, Fan, Jia, Zhou, Jian
Publicado 2022